Nephros Property Plant And Equipment Net vs Current Deferred Revenue Analysis

NEPH Stock  USD 1.51  0.01  0.67%   
Nephros financial indicator trend analysis is infinitely more than just investigating Nephros recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nephros is a good investment. Please check the relationship between Nephros Property Plant And Equipment Net and its Current Deferred Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.

Property Plant And Equipment Net vs Current Deferred Revenue

Property Plant And Equipment Net vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nephros Property Plant And Equipment Net account and Current Deferred Revenue. At this time, the significance of the direction appears to have pay attention.
The correlation between Nephros' Property Plant And Equipment Net and Current Deferred Revenue is -0.71. Overlapping area represents the amount of variation of Property Plant And Equipment Net that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Nephros, assuming nothing else is changed. The correlation between historical values of Nephros' Property Plant And Equipment Net and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Net of Nephros are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Property Plant And Equipment Net i.e., Nephros' Property Plant And Equipment Net and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-0.71
Relationship DirectionNegative 
Relationship StrengthWeak

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from Nephros' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nephros current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.The Nephros' current Issuance Of Capital Stock is estimated to increase to about 6 M, while Selling General Administrative is projected to decrease to under 5.1 M.
 2021 2022 2023 2024 (projected)
Gross Profit5.7M4.7M8.4M8.8M
Total Revenue10.4M10.0M14.2M14.9M

Nephros fundamental ratios Correlations

0.21-0.06-0.240.98-0.120.80.63-0.070.4-0.230.610.580.880.68-0.58-0.92-0.610.89-0.490.98-0.23-0.430.70.540.99
0.210.390.410.080.380.170.380.290.36-0.230.20.180.30.23-0.05-0.18-0.40.460.470.11-0.24-0.140.320.230.13
-0.060.390.53-0.10.33-0.3-0.040.090.04-0.27-0.070.29-0.11-0.170.440.180.240.10.34-0.12-0.270.14-0.18-0.15-0.1
-0.240.410.53-0.310.03-0.37-0.020.09-0.38-0.29-0.09-0.23-0.38-0.21-0.020.30.52-0.070.32-0.33-0.290.18-0.49-0.2-0.26
0.980.08-0.1-0.31-0.10.740.58-0.060.32-0.180.510.580.840.62-0.56-0.94-0.540.8-0.530.99-0.18-0.370.630.490.99
-0.120.380.330.03-0.1-0.470.010.450.1-0.26-0.480.0-0.19-0.290.450.010.16-0.070.66-0.12-0.270.39-0.1-0.3-0.15
0.80.17-0.3-0.370.74-0.470.44-0.160.44-0.070.810.480.860.85-0.74-0.68-0.820.74-0.620.78-0.07-0.460.750.790.78
0.630.38-0.04-0.020.580.010.44-0.120.21-0.290.4-0.090.630.37-0.43-0.73-0.390.60.00.58-0.3-0.260.440.280.61
-0.070.290.090.09-0.060.45-0.16-0.120.190.02-0.120.05-0.31-0.110.130.03-0.080.10.4-0.060.020.550.04-0.09-0.12
0.40.360.04-0.380.320.10.440.210.190.190.260.410.510.30.02-0.27-0.760.60.10.30.19-0.350.840.320.29
-0.23-0.23-0.27-0.29-0.18-0.26-0.07-0.290.020.19-0.48-0.05-0.14-0.490.260.24-0.18-0.230.01-0.191.0-0.160.2-0.44-0.24
0.610.2-0.07-0.090.51-0.480.810.4-0.120.26-0.480.380.650.91-0.64-0.48-0.560.64-0.510.56-0.48-0.310.450.870.59
0.580.180.29-0.230.580.00.48-0.090.050.41-0.050.380.560.49-0.04-0.38-0.470.55-0.330.59-0.06-0.310.470.430.56
0.880.3-0.11-0.380.84-0.190.860.63-0.310.51-0.140.650.560.76-0.51-0.82-0.770.78-0.450.86-0.15-0.620.770.680.87
0.680.23-0.17-0.210.62-0.290.850.37-0.110.3-0.490.910.490.76-0.71-0.6-0.60.64-0.510.67-0.49-0.280.470.980.68
-0.58-0.050.44-0.02-0.560.45-0.74-0.430.130.020.26-0.64-0.04-0.51-0.710.540.34-0.510.51-0.580.260.09-0.29-0.65-0.6
-0.92-0.180.180.3-0.940.01-0.68-0.730.03-0.270.24-0.48-0.38-0.82-0.60.540.52-0.720.4-0.950.240.4-0.58-0.48-0.94
-0.61-0.40.240.52-0.540.16-0.82-0.39-0.08-0.76-0.18-0.56-0.47-0.77-0.60.340.52-0.690.2-0.57-0.170.46-0.93-0.57-0.55
0.890.460.1-0.070.8-0.070.740.60.10.6-0.230.640.550.780.64-0.51-0.72-0.69-0.210.78-0.23-0.330.780.520.82
-0.490.470.340.32-0.530.66-0.620.00.40.10.01-0.51-0.33-0.45-0.510.510.40.2-0.21-0.550.00.4-0.19-0.45-0.56
0.980.11-0.12-0.330.99-0.120.780.58-0.060.3-0.190.560.590.860.67-0.58-0.95-0.570.78-0.55-0.19-0.380.620.550.99
-0.23-0.24-0.27-0.29-0.18-0.27-0.07-0.30.020.191.0-0.48-0.06-0.15-0.490.260.24-0.17-0.230.0-0.19-0.160.2-0.44-0.24
-0.43-0.140.140.18-0.370.39-0.46-0.260.55-0.35-0.16-0.31-0.31-0.62-0.280.090.40.46-0.330.4-0.38-0.16-0.51-0.24-0.43
0.70.32-0.18-0.490.63-0.10.750.440.040.840.20.450.470.770.47-0.29-0.58-0.930.78-0.190.620.2-0.510.40.63
0.540.23-0.15-0.20.49-0.30.790.28-0.090.32-0.440.870.430.680.98-0.65-0.48-0.570.52-0.450.55-0.44-0.240.40.54
0.990.13-0.1-0.260.99-0.150.780.61-0.120.29-0.240.590.560.870.68-0.6-0.94-0.550.82-0.560.99-0.24-0.430.630.54
Click cells to compare fundamentals

Nephros Account Relationship Matchups

Nephros fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets11.6M18.5M17.7M11.0M11.9M7.5M
Other Current Liab300K341K448K268K312K456.2K
Total Current Liabilities2.4M1.3M2.4M1.4M2.1M1.6M
Accounts Payable959K423K1.3M740K873K711.0K
Cash4.2M8.2M7.0M3.6M4.3M2.7M
Other Assets32K1.8M89K54K62.1K59.0K
Common Stock Shares Outstanding7.5M9.1M10.0M10.3M10.4M10.9M
Other Current Assets61K237K558K188K132K161.6K
Total Liab3.9M2.9M2.9M2.1M3.5M2.9M
Property Plant Equipment1.2M295K1.1M1.1M1.3M1.3M
Short Long Term Debt Total2.5M2.2M1.1M1.1M1.8M1.7M
Total Stockholder Equity4.7M12.5M11.7M5.6M8.4M8.8M
Property Plant And Equipment Net1.2M1.3M1.1M1.1M2.0M2.1M
Net Debt(1.6M)(6.1M)(5.9M)(2.5M)(2.5M)(2.3M)
Retained Earnings(127.3M)(131.9M)(135.7M)(142.8M)(144.4M)(151.6M)
Non Current Assets Total3.3M3.4M4.0M2.7M3.5M1.8M
Non Currrent Assets Other18K32K89K54K86K81.7K
Cash And Short Term Investments4.2M8.2M7.0M3.6M4.3M3.7M
Liabilities And Stockholders Equity11.6M18.5M17.7M11.0M11.9M7.8M
Non Current Liabilities Total1.5M1.6M511K706K1.4M2.0M
Other Stockholder Equity131.9M144.3M147.3M148.4M152.8M109.1M
Property Plant And Equipment Gross1.2M1.3M1.1M1.1M2.9M3.1M
Total Current Assets8.3M15.2M13.6M8.3M8.4M6.1M
Short Term Debt1.2M1.0M561K387K892K744.8K
Inventory2.6M5.3M4.8M3.2M2.5M1.4M
Net Receivables1.0M1.4M1.6M1.3M1.5M806.7K
Long Term Debt623K846K95K1K900.0855.0
Intangible Assets1.4M1.2M2.1M825K652K1.1M
Net Tangible Assets2.6M10.6M8.9M4.0M4.6M2.7M
Capital Surpluse122.9M127.8M131.9M144.3M165.9M134.3M

Currently Active Assets on Macroaxis

When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Household Appliances space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.09)
Revenue Per Share
1.313
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.08)
Return On Equity
(0.16)
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.